TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 4 | 2 | 4 | -3 | -15 | -13 | 162 | 23 |
| P | %wins | 75 | 75 | 50 | 25 | 25 | 100 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/16 18:52 | 8/18/16 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Shaffer James P | CA | O | Chief Bu | P | 49 | 15.70 | 1 | 3 | 125 | 6 | D | -91 | -1 | 14 | -21 | -15 | -19 | -17 | -12 | 5 | 5 | -11 | -22 | -29 | ||
6/14/16 18:45 | 6/13/16 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Shaffer James P | CA | O | Chief Bu | P | 28 | 22.17 | 0 | 1 | 100 | 2 | D | -87 | -35 | 10 | 27 | 2 | 4 | -10 | -9 | -3 | -7 | -8 | -33 | -44 | ||
5/23/16 18:37 | 5/19/16 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Shaffer James P | CA | O | Chief Bu | P.m | 25 | 19.80 | 0 | 1 | New | 1 | D | -85 | -38 | 20 | 44 | 0 | -2 | 2 | 2 | 1 | 4 | 1 | -21 | -36 | ||
11/14/12 19:06 | 11/14/12 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Shaffer James P | CA | O | VP,Chief | P | 104 | 5.22 | 4 | 20 | 317 | 26 | D | -28 | -35 | -29 | -9 | -30 | -9 | -2 | 0 | 5 | 12 | 6 | 15 | 56 | 162 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |